Muhammad Al-Hajj
Directeur Technique/Scientifique/R&D chez IO BIOTECH, INC.
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Muhammad Al-Hajj
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
95
| Public Company | Pharmaceuticals: Major | 95 |
| Unknown | 22 | ||
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA.
3
| Non-Profit Organization | Medical/Nursing Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Muhammad Al-Hajj via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
| DIAGEO PLC | Beverages: Alcoholic | Director/Board Member Director/Board Member Director/Board Member | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman Independent Dir/Board Member Director/Board Member Director of Finance/CFO Director of Finance/CFO | |
| BG GROUP | Contract Drilling | Chairman Director of Finance/CFO | |
| VODAFONE GROUP PLC | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Domantis Ltd. develops domain antibody therapeutics for treating highly unmet diseases. It enables DABS to serve as building blocks for therapeutics simultaneously directed at more than one disease target. The company was founded in December 2000 and is headquartered Middlesex, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Director/Board Member Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree | |
| Union College (New York) | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| SHELL PLC | Integrated Oil | Director/Board Member Corporate Officer/Principal | |
The Financial Reporting Council Ltd.
 The Financial Reporting Council Ltd. Miscellaneous Commercial ServicesCommercial Services The Financial Reporting Council Ltd. is a regulatory body that oversees auditors, accountants, and actuaries. The non-profit company is based in London, UK. The British company is responsible for setting the Corporate Governance and Stewardship Codes and promoting transparency and integrity in business. The company's work is aimed at investors and others who rely on company reports, audit, and high-quality risk management. The CEO of the company is Sarah Rapson. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| University of Zurich | College/University | Graduate Degree Doctorate Degree | |
| Fudan University | College/University | Undergraduate Degree Undergraduate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Consumer Healthcare Products Association | Director/Board Member Director/Board Member | ||
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Johns Hopkins Bloomberg School of Public Health | College/University | Graduate Degree Consultant / Advisor | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
 GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK. | Financial Conglomerates | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Glaxosmithkline Australia Pty Ltd.
 Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| SHATTUCK LABS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
World Self-Medication Industry Association
 World Self-Medication Industry Association Miscellaneous Commercial ServicesCommercial Services The World Self-Medication Industry Association is a non-profit, voluntary association that contributes to WHO's public health goals through its specialized expertise in self-care and responsible self-medication with non-prescription medicines. The association is based in Nyon, Switzerland. The association is a member of the UHC2030 Private Sector Constituency and supports the recent Private Sector Statement that was initiated by the World Economic Forum. The association calls on governments and policymakers to take measures to improve the overall integration of self-care into national health policies. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Founder Corporate Officer/Principal | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| HALEON PLC | Medical Distributors | Chief Executive Officer Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 22 |
| Royaume-Uni | 18 |
| Danemark | 7 |
| France | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 19 |
| Consumer Services | 19 |
| Commercial Services | 5 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 514 |
| Corporate Officer/Principal | 262 |
| Independent Dir/Board Member | 164 |
| Chairman | 99 |
| Chief Executive Officer | 98 |
Relations les plus connectées
| Insiders | |
|---|---|
| Claus Asbjørn Andersson | 41 |
| Jack Nielsen | 38 |
| Anjali Bansal | 37 |
| Anne Michelle Whitaker | 35 |
| James Murdoch | 32 |
| Simon Dingemans | 31 |
| Urs Rohner | 30 |
| Lynn Elsenhans | 27 |
| Catherine Sohn | 27 |
| Philip Hampton | 24 |
| Gerardus Johannes Wijers | 23 |
| James Shannon | 22 |
| Emmanuelle Coutanceau | 21 |
| H. Culp | 20 |
| Michael Owen | 20 |
- Bourse
- Insiders
- Muhammad Al-Hajj
- Connexions Sociétés
